IBA signs sponsored research deal with MD Anderson to assess proton therapy cost-effectiveness

  • IBA signed a sponsored research agreement with the University of Texas MD Anderson Cancer Center to build health-economics evidence for proton therapy.
  • No study results have been presented; the work is scheduled to generate future clinical and economic evidence.
  • Research aims to clarify whether proton therapy delivers better overall value than alternative cancer radiation options by linking outcomes to total care costs.
  • Focus includes cost-effectiveness across multiple cancer indications, factoring reduced side effects, long-term impacts, payer costs, patient costs, and societal costs.
  • Data is intended to support reimbursement discussions, patient access decisions, and value-based allocation of healthcare resources.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBA - Ion Beam Applications SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606100100OMX_____CNEWS_FR_GNW1001186773_fr) on June 10, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.